相关实验视频
Updated: Jan 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
型肝炎病毒和心血管疾病:当前的知识和未满足的需求
Chih-Wen Wang1,2, Jee-Fu Huang1,3,4, Ming-Lung Yu1,3,4
1Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
肝炎C病毒 (HCV) 感染显著增加心血管疾病 (CVD) 的风险. 直接作用抗病毒药物 (DAA) 治疗可以降低这种风险,但长期结果和脂质特征变化需要进一步研究.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
背景情况:
- 型肝炎病毒 (HCV) 感染与心血管疾病 (CVD) 患病率和死亡率的增加有关.
- 慢性HCV,特别是在血液透析的末期病患者中,具有较高的心血管疾病风险.
- 致病机制包括氧化应激,内皮损伤,代谢失调和慢性炎症,导致血管损伤和斑块不稳定.
研究的目的:
- 审查HCV感染和心血管疾病之间的关系.
- 评估直接作用抗病毒疗法 (DAA) 对HCV患者心血管疾病风险的影响.
- 确定在DAA时代管理心血管疾病风险的未满足需求.
主要方法:
- 文献综述和对HCV和心血管疾病现有研究的综合.
- 对将HCV与心血管并发症联系起来的致病机制的分析.
- 评估DAA治疗结果,以减少心脏病风险和潜在的不良影响.
主要成果:
- DAA治疗实现了高持续病毒学反应率 (>95%) 并显著减轻心血管疾病风险.
- 治疗DAA可以改善内皮功能,减少炎症标志物,降低心血管疾病事件发生率.
- 在DAA治疗后,脂质样本的矛盾增加和对心律失常风险的不明确影响被注意到. 表观遗传变化可能会持续存在.
结论:
- DAA疗法有效降低与HCV感染相关的心血管疾病风险.
- 需要进一步的研究来了解长期CVD结果,脂质谱的变化和DAA治疗后心律失常风险.
- 阐明未满足的需求对于完善查指南和在DAA时代在HCV患者中管理心血管疾病至关重要.
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

